We hereby submit the disclosure on grant of ESOP to eligible employees.

August 7, 2026 BSE Limited National Stock Exchange of India Limited Corporate Relationship Department, Exchange Plaza, 5th Floor, Plot No C/1, Phiroze Jeejeebhoy Towers, G Block, Bandra-Kurla Complex, Dalal Street, Mumbai - 400 001 Bandra (East), Mumbai - 400 051 Scrip Code: 540735 Symbol: IRIS Dear Sir / Madam, Sub: Outcome of Nomination and Remuneration Committee Meeting Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), we wish to inform you that the Nomination and Remuneration Committee ("NRC") of the Board of Directors of IRIS RegTech Solutions Limited ("Company"), at its meeting held on August 7, 2026, has, inter alia, approved the grant of 1,21,000 Stock Options to the eligible employee(s) of the Company under the IRIS RegTech Solutions Limited Employee Stock Option Plan 2023 ("IRIS ESOP 2023"). The disclosure required pursuant to Regulation 30 of the Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD- PoD-1/P/CIR/2023/123 dated July 13, 2023 is enclosed as Annexure A. The meeting of the NRC commenced at 10:00 IST and concluded at 11:00 IST. Kindly take the above information on record. Thanking You, Yours faithfully, For IRIS RegTech Solutions Limited Santoshkumar Sharma Company Secretary & Compliance Officer (ICSI membership number – ACS 35139) Encl: a/a Annexure-A Disclosure under Regulation 30 read with Schedule III of the SEBI Listing Regulations Sr. Particular Details 1 Brief details of options granted 1,21,000 Stock Options have been granted by the NRC to eligible employee(s) under IRIS ESOP 2023. 2 Whether the scheme is in terms of Yes SEBI (SBEB) Regulations, 2021 (if applicable); 3 Total number of shares covered by 1,21,000 equity shares with a face value of Rs. 10/- each of the Company. Each stock these options; option carries the right to apply for and be allotted 1 (one) equity share of face value of Rs. 10/- each of the Company. 4 Pricing formula/Exercise Price The Exercise Price for the Options granted to eligible employees shall be the INR 10/-. 5 Options vested / Vesting Schedule; Options Vested till date - 2,24,500 Vesting Schedule - After the disclosure of financial results for financial year end March 2028-29, subject to the achievement of performance criteria as decided by the Nomination and Remuneration Committee. 6 Time within which option may be Options which have vested will need to be exercised within 5 years from the date of such exercised vesting. Any vested options not so exercised within the prescribed period shall lapse. 7 Options exercised 20,130 (as of the date under IRIS ESOP 2023) 8 Money realized by exercise of options INR 39,12,160 /- 9 The total number of shares arising as 20,130 (as of the date under IRIS ESOP 2023) a result of exercise of option 10 Options lapsed 43,500 (as of the date under IRIS ESOP 2023) 11 Variation of terms of options Not Applicable 12 Brief details of significant terms Vesting is subject to the achievement of performance criteria as decided by the Nomination and Remuneration Committee and continuation of employment and subject to other conditions specified in the grant letter and the IRIS ESOP 2023 Scheme. The Option Grantees would be entitled to a maximum of 1,21,000 options. 13 Subsequent changes or cancellation Not Applicable or exercise of such options; 14 Diluted earnings per share pursuant to Not Applicable issue of equity shares on exercise of options For IRIS RegTech Solutions Limited Santoshkumar Sharma Company Secretary & Compliance Officer (ICSI membership number – ACS 35139)